Veru's COVID drug: placebo group had unusually hig
Post# of 148190
(Total Views: 424)
Posted On: 11/07/2022 4:05:14 PM
Veru's COVID drug: placebo group had unusually high death rate, other factors may make their data suspect, but FDA is "hinting" that they will give them EUA for the drug anyway.
https://endpts.com/fda-tentatively-hints-at-e...of-adcomm/
Many of us are familiar with drugs that had placebo groups with unusually good results, so that drugs that were far more effective than the historical percentages in non-treated groups were nevertheless considered to have failed their trials. To see one with an unusually high death rate in the placebo group -- and yet the FDA is not going to issue a letter chastising them for "cherry picking data"?
Anybody who thinks that the FDA didn't single out CYDY for a nasty letter, 2 days after Nader prematurely opened his big mouth about an as-yet unsigned deal with the Philippines, thus killing that deal -- might want to consider this.
https://endpts.com/fda-tentatively-hints-at-e...of-adcomm/
Many of us are familiar with drugs that had placebo groups with unusually good results, so that drugs that were far more effective than the historical percentages in non-treated groups were nevertheless considered to have failed their trials. To see one with an unusually high death rate in the placebo group -- and yet the FDA is not going to issue a letter chastising them for "cherry picking data"?
Anybody who thinks that the FDA didn't single out CYDY for a nasty letter, 2 days after Nader prematurely opened his big mouth about an as-yet unsigned deal with the Philippines, thus killing that deal -- might want to consider this.
(5)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼